Nashat Amir 4

What Happened
Nashat Amir, a reported 10% owner of Camp4 Therapeutics (CAMP), received a grant/award of 28,000 derivative shares on June 10, 2026. The Form 4 lists the per-share amount as $0.00 (derivative), so the reported acquisition value is $0 on the filing. This transaction is recorded as an award/grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-10; Form 4 filed: 2026-06-12 (appears timely under Form 4 rules).
• Security: 28,000 derivative shares (award/grant), price reported $0.00 per share; total reported value $0.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: The underlying shares vest in full on the earlier of the first anniversary of the grant date or the issuer’s next annual meeting of stockholders, subject to continued service (see F1).
• Transaction code: A = Award/Grant (derivative).

Context
This is a derivative award subject to vesting, not an immediate purchase or sale. Grants like this are commonly used for compensation or incentive purposes and do not by themselves indicate a buy or sell signal. There is no indication in the filing that any shares were sold or that a cashless exercise occurred.